
NLS Pharma
Treatments for attention deficit hyperactivity disorder and other neurological disorders.
Market cap
$13.7m
Enterprise value
$15m
Share price
$2.90 NLSP
Company register number
CHE-348.607.509
Authorizing premium user...
Treatments for attention deficit hyperactivity disorder and other neurological disorders.